{"name":"Chelsea Therapeutics","slug":"chelsea-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":172872603,"netIncome":-231477643,"cash":46502522,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQQjRITlJBRHZ5dVFnckxOei1uUFJSTWh0bDVDQlZuSlRtZ20zOFhCaGVXWHV4OEVVWlVhM1FZWEpWc2NaWXNzSTBwNkx3SG4wdUhYMXdlVlBqTk5PRmcteDF5RjZXOE9JQWFCTjZRekdBMHFMRlBCQ0I3UzI3LTE3dHR3VGxMTm5LN05vbmZWVk5KWG0wcDhMQTZ2OFpaVjVhMHBQWXVrc2tzVGQ3SXU1YV9R?oc=5","date":"2025-08-05","type":"deal","source":"Pharmaceutical Online","summary":"Bristol Myers Squibb Forms Immunology Company With Finance Partner - Pharmaceutical Online","headline":"Bristol Myers Squibb Forms Immunology Company With Finance Partner","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxObTBfOUZfY0RaakNoUkRlMkRVOG81VUNtT2RZWjR6eXpmYlBLajZ1aFdPb3VnbW93X3V2dU55LWZURnFrbEUwd0FLbG12RGduZjhkZUhyQnp0VUxHRUJSLTZueUNGaXRmWHZJLV9DdEZSZGtVYmd6MjVRQzlxWlNwcTE4X2x4UEdrMG0wVng2OEVjZWdXekRlbEFHOGxmYmd3QnRLemRielNCbkhzNFppaGxvcnFhWHF1elhIb3dELXJIN0U?oc=5","date":"2025-05-30","type":"regulatory","source":"Politico","summary":"FDA denies ultra-rare drug but offers path to ‘yes’ - Politico","headline":"FDA denies ultra-rare drug but offers path to ‘yes’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNLUhiN2pBWktaV083SHdTUUVmR0g4X1FzUE1NVUxLcUpnWThEYXhIOFFvN2FoX080MElBTi1fSU1Pc3pSRWxsM0hoOTBkcXAwRC02TEl1WGVpSGNmUzlwdnJSZF9WWDNxbzdvSTd2el9VdnM5d2xacjQ0M1pQcUU4TlZuYTQtYXR3ZjBBOUR1eTFyazJCdDFJODdTQQ?oc=5","date":"2025-03-07","type":"trial","source":"Food and Drug Law Institute (FDLI)","summary":"From Secret Tests to Therapy Trials: MDMA’s Long Road to Legitimacy - Food and Drug Law Institute (FDLI)","headline":"From Secret Tests to Therapy Trials: MDMA’s Long Road to Legitimacy - Food and Drug Law Institute (FDLI)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNbjJpMUlyUXpZeHFYNUlhNDJBbWp4TXdxN3ZwZ1E5UHh6Q3lVWUhIa01QOU10VWFHWXhwTUpWZ19EV1Z3QW9EakJOUVpuUUFmREdHQnVWS3ZRN2I4WF9HVDZfODloVTg4ZTMwWG9wMUNnbEU1N1haNkJOQXRpUV9lWWVmdk1fYlpCbTlTUUtxczBObTNibWotTm9iRUFTOGpIbFpDM3BwbklBRExmUHB2d1Bialpaa1lNa1N2WnJmNzltTVFSVldfem1la3VXMG5YbkRPMlBBMVdnOHZ6MzVwWWhhWHByZ29UZ25hUnVBLWdYMWZ2OXZMVDlaZXdBdl8tSVBB?oc=5","date":"2025-02-17","type":"pipeline","source":"PR Newswire","summary":"Multiple System Atrophy Market Set to Experience Significant Growth with Breakthrough Therapies by 2034 | DelveInsight - PR Newswire","headline":"Multiple System Atrophy Market Set to Experience Significant Growth with Breakthrough Therapies by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQX3ZFQUt5Y3I1aHRKb21vVS00c05ITGtYdE90UWNaaEZZZDdxZVZHQWRnMDZBREpkZk5WdElfUlhFbXpjUHZUM2JiN0xubUEzUG9TUGFyNVo3TVh1RDNnMEMzVGdoai1xZ1p1WHZGRUlXOGI5aVl2R04wc3NCUGpYYzZGX1ZTVVE?oc=5","date":"2024-10-14","type":"pipeline","source":"Yahoo Finance","summary":"Multiple System Atrophy (MSA) Market is expected to reach US$ 202.3 Million by 2031, Report by CoherentMI - Yahoo Finance","headline":"Multiple System Atrophy (MSA) Market is expected to reach US$ 202.3 Million by 2031, Report by CoherentMI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQT0VtSHI0QjNBYS1xMktTU2NZWVZoN1Q5SlR1TkVmSFhJOUNCTUtwbHpqaXRuWUpxTFFVNmkwX01xNGF0LV9DX1hiNEF2S0dTaE5vVzZVemZ6VmpiOEw1WmpvX2lMMFpoZnJmSWJFdmgxc2JOUFR4djRmVG9ncUgwWWVRbUk2S09IU3VLVzFnS19WY1MwSEZwaFpicXBuT2V5ZlUteVFvT3FLTXg4eVh2U3RrbmdqVzNuMlZUUFNGcw?oc=5","date":"2024-09-30","type":"pipeline","source":"Department of Justice (.gov)","summary":"U.S. Attorney Announces Charges Against 18 Defendants In Scheme To Manufacture And Distribute Millions Of Deadly Counterfeit Pharmaceuticals Through Fake Online Pharmacies - Department of Justice (.go","headline":"U.S. Attorney Announces Charges Against 18 Defendants In Scheme To Manufacture And Distribute Millions Of Deadly Counter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOWG56ZW1JanZxcndlb21CbUxkY0NTX1FsZWJxWUYyQm9oeUxPX2ZCamlkQ3Bmd3ZaLWUyazJIRkQ0N041NHdZajFKTzY5Xy1saWQybFp5LWRUcDBjc2VfR0hYcDdONnM0V2oxbWhzSnhacG5nd1JkRnhxUFl0a3ZkN09ZcWI2RkdFTHNWbk1IS2dJUXRta0w3c3JvaGxwakpOMGdzanhlTHNYTHJUWFBLX0xjdzJUZlE?oc=5","date":"2020-02-07","type":"pipeline","source":"pharmaphorum","summary":"Q&A: Fortress Biotech’s Lindsay Rosenwald on breathing new life into sidelined drugs - pharmaphorum","headline":"Q&A: Fortress Biotech’s Lindsay Rosenwald on breathing new life into sidelined drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE45UnpGUXBlT2NCN05OYTVrWDQtUHFXb3lrV29Lc0dYYUJnWm55WlBOVEN0Ml96cHIzV0phNEhDbEYwUnhoQ0E1OU9DaVVRR2h6U0MzT1VB?oc=5","date":"2018-07-03","type":"pipeline","source":"nature.com","summary":"People - nature.com","headline":"People","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFA5YWdtMGExbTc5S1lxQlU2U21RRlV3SXR1Y0VaQnlOekVkWUIzbTNia2MzT3dOT3hkQk03OUJ6Z0Rwa0Ffb1pTUnRVN1p2LUs3clN1ajFmUkpud2V5MWRBdTc5RTJYMlBaeGxtd01BR3RpZGFlYzdYU1drV3I3ODQ?oc=5","date":"2017-03-09","type":"pipeline","source":"businessnc.com","summary":"Oliveto named CEO of Milestone Pharmaceuticals USA - businessnc.com","headline":"Oliveto named CEO of Milestone Pharmaceuticals USA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE1SUEQwaVNkb1E0LW9EVm9wQ3pUNUhWdWFsQTVxNXlENkFvSlE2UUFJTUFHd2c2am1rZHRwbE5xVzhsQjZnbTFoZ0hrOWVvWk1qbnF0WDEyN2JJdm9WSDVibVU5aFA?oc=5","date":"2015-02-02","type":"pipeline","source":"cen.acs.org","summary":"The Year In New Drugs - cen.acs.org","headline":"The Year In New Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNdTd6MXdfY19ROVkwWW81aFd4akR3XzlmWklCWHdkbHh3QnZQa0NRaHNMYnFJN3h1ZzNQc2JqUEJqZjEwVGVtejlZaEUyTDZPVko2cUY5a2ZZMEVjaDV1UERLT1AzM0ZtTlNvLTl2WVdaOEw2WUxLa3BvMldteHNoaWdFY3J0S1JVVDd0c2tB?oc=5","date":"2014-02-19","type":"regulatory","source":"PMLiVE","summary":"FDA approves Chelsea’s rare blood pressure drug - PMLiVE","headline":"FDA approves Chelsea’s rare blood pressure drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPZlZ4c1V6Szc5MkdSMGNZS3NielRCMzRuTGowXzVsVGI3SnlSdHIxckVudWFvOXgyeEpGb3RXbm5IdWpZQ09mNTBtTDhRNGFaTEk2YkF2c2FLQm1nVU9tOGpTZUJxVWlIc2R0cmZiQklydmRoMkVObmhBd081d295b29NQjFLMVFsNVlMbEpMWTR6VlRWU1k0cXdMRkRHS1o2VzNOSlFjeVNYbEE?oc=5","date":"2014-01-27","type":"pipeline","source":"The Business Journals","summary":"Chelsea Therapeutics names Joseph Oliveto as CEO - The Business Journals","headline":"Chelsea Therapeutics names Joseph Oliveto as CEO","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":172872603,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-231477643,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":46502522,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}